Insider Selling: Cabot (NYSE:CBT) CEO Sells $237,604.50 in Stock

Cabot Corporation (NYSE:CBT) CEO Sean Keohane sold 2,779 shares of the business’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $85.50, for a total value of $237,604.50. Following the sale, the chief executive officer directly owned 288,873 shares of the company’s stock, valued at approximately $24,698,641.50. This trade represents a 0.95% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Cabot Stock Performance

Cabot stock opened at $83.67 on Friday. The stock’s 50-day moving average is $87.62 and its 200-day moving average is $81.19. The company has a market cap of $4.32 billion, a price-to-earnings ratio of 23.57, a price-to-earnings-growth ratio of 11.11 and a beta of 0.84. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. Cabot Corporation has a 12 month low of $58.33 and a 12 month high of $94.53.

Cabot (NYSE:CBT) last issued its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. The business had revenue of $982.00 million during the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The company’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Equities analysts anticipate that Cabot Corporation will post 6.35 earnings per share for the current year.

Cabot Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be paid a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a yield of 2.3%. The ex-dividend date is Friday, August 28th. Cabot’s payout ratio is currently 53.24%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of CBT. Torren Management LLC acquired a new stake in Cabot during the 4th quarter valued at approximately $26,000. Rothschild Investment LLC increased its holdings in Cabot by 170.4% during the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after purchasing an additional 259 shares during the last quarter. Northwestern Mutual Wealth Management Co. acquired a new position in shares of Cabot in the 2nd quarter valued at approximately $33,000. Global Retirement Partners LLC boosted its stake in shares of Cabot by 1,606.9% during the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 466 shares during the last quarter. Finally, Geneos Wealth Management Inc. boosted its stake in shares of Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 364 shares during the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

Analyst Upgrades and Downgrades

CBT has been the topic of a number of research reports. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research note on Friday, August 21st. JPMorgan Chase & Co. upped their price target on shares of Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a research report on Friday, August 7th. UBS Group lowered their price target on Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a report on Wednesday, August 5th. Truist Financial set a $100.00 price objective on Cabot in a research report on Wednesday, August 5th. Finally, Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $89.00.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.